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Any amendments to protocol:  
 A prediction model development/validation study specific risk of bias 
assessment tool was developed in 2016 (Prediction Study Risk of Bias 
Tool (PROBAST)). Risk of bias assessment was repeated using this tool. 
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Clinical Prediction Models for mortality and functional outcome following 
Ischemic Stroke: A Systematic Review and Meta-Analysis. 
 
Review Title and Timescale 
1. Review Title:  
Clinical Prediction Models for mortality and functional outcome following Ischemic Stroke: A 
Systematic Review and Meta-Analysis 
2. Original Language Title 
Not applicable. 
3. Anticipated or Actual Start Date 
January 2015 
4. Anticipated Completion Date 
March 2015 
5. Stage of Review at Time of This Submission 
*Checklist 
The review has not yet started [ ] 
Review Team Details 
6. Name of contact 
Ms. Marion Fahey. 
PROSPERO Format Protocol 
 
7. Named Contact E-mail 
Marion.fahey@kcl.ac.uk 
8. Named Contact Address 
King's College London  
Department of Primary Care and Public Health Sciences  
Faculty of Life Sciences & Medicine  
9th Floor, Capital House  
42 Weston St  
LONDON SE1 3QD  
9. Named Contact phone Number 
02078488732  
10. Organisational Affiliation of the Review 
King's College London 
http://www.kcl.ac.uk/medicine/index.aspx 
11. Review Team Members and their Organisational Affiliations 
Ms. Elise Crayton,  King’s College London, Department of Primary Care and Public 
Health Sciences 
Dr. Abdel Douiri, King’s College London, Department of Primary Care and Public 
Health Sciences 
Professor Charles Wolfe, King’s College London, Department of Primary Care and 
Public Health Sciences 
12. Funding Sources/Sponsors 
Department of Health and Social Care Research, King’s College London  
13. Conflicts of Interest 
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None Known. 
14. Collaborators 
Not applicable. 
Review Methods 
15. Review question(s) 
What models have been developed to predict mortality after stroke in the mid and long term?  
What models have been developed to predict poor functional outcome after stroke in the mid 
and long term?  
What is the quality of the evidence supporting established stroke risk prediction models of 
death and poor functional outcome in the mid and long term following stroke?  
 
16. Searches: 
Literature search: 
A multi-method evidence synthesis weighted toward citation and reference list searching 
utilising validated search filter. 
Meta-analysis: 
Bayesian meta-analysis will be conducted using the Markov Chain Monte Carlo (MCMC) 
simulation with random effects model. 
17. URL to Search Strategy 
18. Condition or domain being studied  
The focus of this review is stroke prognostication. ‘In clinical medicine, the term prognosis 
refers to the risk of future health outcomes in people with a given disease or health condition. 
Prognosis research is thus the investigation of the relations between future outcomes 
PROSPERO Format Protocol 
 
(endpoints) among people with a given baseline health state (start point) in order to improve 
health’ (Hemingway 2013). The start point in this review is stroke and the endpoint stroke 
recovery measured proximally as death or disability. The focus of this review is not the 
resolution of stroke, but rather the prediction of the outcomes of that stroke. This review fits 
within the broader scope of prognosis research.  
Five distinct types of multivariable prediction research have been identified 
(Bouwmeester 2012): Predictor finding studies, Model development studies without external 
validation, model development studies with external validation, external validation studies 
without or with model updating and model impact studies. 
 A prognostic model is a formal combination of multiple predictors (Identified as any 
measure that, among people who have had a stroke, is associated with a subsequent increased 
or decreased risk of death, disability or institutionalisation (Riley, Hayden et al. 2013) from 
which risks of a specific endpoint can be calculated for individual patients. Other names for a 
prognostic model include prognostic (or prediction) index or rule, risk (or clinical) prediction 
model, and predictive model. For an individual with a given state of health (post stroke), a 
prognostic model converts the combination of predictor values to an estimate of the risk of 
experiencing a specific endpoint (death, disability or institutionalisation) within a specific 
period. Ideally this produces an estimate of the absolute risk (absolute probability) of 
experiencing the endpoint, but it may instead provide a relative risk or risk score (Harrell 2001; 
Steyerberg 2009; Moons, 2009). As we desire as comprehensive a review as possible for the 
prognostic accuracy of these models, we will consider all multivariable models, including all 
relevant populations and outcomes that have been examined. We will thus be using a broad 
approach to the inclusion criteria.  
19. Participants/ population 
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Target patients are individuals who have had an ischemic stroke. Populations for this review 
will be broadly inclusive, involving any country, both sexes and patients managed in the 
community or in hospital. Paediatric stroke, secondary stroke or any extremes which do not 
reflect the general population will be excluded. 
20. Intervention(s), exposure(s) 
This review is intended to identify multivariable formal clinical prediction models estimating 
risk of poor functional outcome and mortality in the mid and long term following 
haemorrhagic stroke. Quality assessment criteria will be applied to review the methodical 
quality of included models.  
21. Comparator(s)/ control 
The various models identified will be compared to recommended best practice. Reviews and 
Meta-analysis of prognostic studies are relatively new within the field of review and so 
methods have not been sufficiently standardised or adopted. New research publications are 
published frequently describing advances in proposed methods (Moons 2014). Thus this 
review will be informed by current, appropriate guidance (Bouwmeester 2012; Collins 2011; 
Mallett 2010a; Mallett 2010b; Van Dieren 2012; Steyerberg 2013). 
22. Types of study to be included initially  
 Prediction model development with internal validation only 
 Prediction model development with external validation by independent data 
 External model validation with or without model updating 
 Impact assessment studies-randomised or non-randomised 
This review will focus on multivariable, formal clinical prediction models, excluding studies 
that investigated a single predictor, test or marker (such as single diagnostic test accuracy or 
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single prognostic marker studies), studies that investigated only causality between one or 
more variables and an outcome and predictor finding studies. 
 
23. Context 
No health care systems, country of origin or place of residence will be excluded a priori. 
Models that have been developed for use in both the primary and acute care setting will be 
identified and evaluated. 
24. Primary Outcome(s) 
Mortality risk 
Risk of poor functional outcome 
25. Secondary Outcome(s) 
There are no secondary outcomes that will be considered in this review. 
26. Data Extraction (Selection and Coding) 
Selection of studies 
Studies will be selected independently and in duplicate by an independent review author (E.C). 
Disagreement will be resolved by discussion or by a third review author as arbiter(A.D). We 
will initially screen studies by title and will receive full reports for potentially relevant studies. 
For these studies, we will use a predefined electronic spreadsheet in conjunction with the 
Covidence software to assess and document studies for inclusion and exclusion according to 
the above selection criteria. We will document study selection in a detailed flowchart.  
Data extraction and management 
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Data extraction will be comprehensive and will broadly include the following: 
• Data sources (e.g. prospective vs retrospective cohort, nested case-control, case-cohort, 
sample size). 
• Source of participants (e.g. country, facility type, health care system). 
• Outcome(s) definitions. 
• Candidate predictors (e.g. demographics, stroke severity, pre stroke function). 
• Model development (e.g. univariable screening, criteria for prediction selection, 
statistical software). 
• Model performance (e.g. discrimination, calibration). 
• Model evaluation (e.g. development and test data sets, external data sets). 
• Model interpretation. 
• Model impact assessment (Formal assessment or as per model author, generally 
improved outcomes following stroke, lower incidence of recurrence etc.). 
Data extraction will be performed independently and in duplicate by an independent review 
author (E.C). Disagreement will be resolved by discussion or by involving a third reviewer as 
arbiter. Should RevMan be adopted to include a template for prognosis studies throughout the 
duration of this review.  
 
27. Risk of Bias (Quality) Assessment 
*see ammendments 
The QUIPS (QUality In Prognosis Studies) tool has been used successfully by more than 
40 prognosis review teams (Hayden 2006; Hayden 2013). Six domains are critical for 
assessing biases sufficiently large to distort the findings of prognosis research: (1) study 
participation; (2) study attrition; (3) prognostic factor measurement; (4) outcome 
PROSPERO Format Protocol 
 
measurement; (5) study confounding; and (6) statistical analysis and reporting. For each 
domain, three to seven “prompting items” are used to rate the adequacy of reporting by a 
study as yes, partial, no or unsure; an overall rating for each domain is assigned as high, 
moderate or low risk of bias. Two review authors will independently complete the QUIPS 
assessment for each study. We will be guided by previous reports by Bouwmeester et al 
(Bouwmeester 2012), Collins et al (Collins 2011), Mallet et al (Mallett 2010a; Mallett 
2010b), van Dieren et al (van Dieren 2012) and Steyerberg (Steyerberg 2009) . Differences 
will be resolved by consensus or by referral to a third review author. 
GRADE and SOF 
The Grades of Recommendation, Assessment, Development and Evaluation (GRADE) 
framework for judging the quality of evidence has been extended to prognosis factor 
research. Evidence on prognostic models will be evaluated by six factors that may decrease 
quality: (1) phase of investigation; (2) study limitations; (3) inconsistency; (4) indirectness; 
(5) imprecision; and (6) publication bias; and by two factors that may increase quality: (1) 
moderate or large effect size; and (2) exposure response gradient (Huguet 2013). If a 
template for ’Summary of findings’ tables is available, prognostic models with GRADE 
judgement will be displayed. If such a template is not available, a text description of 
GRADE judgement will be provided. 
28. Strategy for Data Synthesis 
This broad review investigates evidence on many prognostic models rather than focusing 
on the predictive accuracy of a single prognostic model. We expect to identify sufficient 
prognostic models to allow both a qualitative and quantitative overview. This would 
include assessment of methods, risk of bias, prediction performance (discrimination, 
calibration) and so forth. We will follow a schema used by van Dieren et al (van Dieren 
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2012). Tabular displays will be used to show the following for each model: (1) participant 
population; (2) number of events/sample size; (3) statistical model type; (4) outcome 
type; (5) number of predictive factors; (6) discrimination; (7) calibration; (8) internal 
validation method; and (9) presentation format of the model. For prognostic models that 
have been externally validated, an additional tabular display will be used to show (1) 
original model name; (2) validation study identifier; (3) external validation participant 
population; (4) number of events/sample size; (5) discrimination; (6) calibration; and (7) 
recalibration. 
Meta-analysis packages in the R statistical language will be used for meta-analysis and 
meta-regression. 
29. Analysis of Subgroups or Subsets 
No subgroups or subset analysis will be stated a priori. 
General Information 
30. Type of Review 
Prognostic  
31.  Language 
English 
32. Country 
England 
33. Other Registration Details 
Not applicable 
34. Reference and/or URL for Published Protocol 
35. Dissemination plans 
Results to be published in relevant journals and used for conference presentations. 
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36. Keywords 
Systematic Review; Meta-analysis; Stroke; Clinical Prediction Model; Stroke Recovery;  
37. Details of Any Existing Review of the same Topic by the Same Authors 
Not applicable. 
38. Current Review Status 
Ongoing 
39. Any Additional Information 
This review is being undertaken to inform the design of a predictive tool suitable for long 
term care settings, both of which will contribute to the authors PhD Thesis. 
40. Details of Final Report/Publication(s) 
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